Shares of Epizyme Inc. (EPZM) have gained nearly 10 percent over the last 1 week as the Company awaits the FDA decision on its New Drug Application for Tazemetostat, slated to be announced on January 23, 2020.
from RTT - Biotech https://ift.tt/2ugSOIE
via IFTTT
No comments:
Post a Comment